Searchable abstracts of presentations at key conferences in endocrinology

ea0026p464 | Thyroid cancer | ECE2011

Both Follicular and Papillary neoplasms in a patient with Hashimoto’s thyroiditis: complete coincidence?

Mousa U , Tutuncu N B

Even though it is unusual, many cases presenting with combinations of thyroid carcinomas have been reported. Concurrent occurances of medullary – papllary carcinoma, follicular – papillary – medullary carcinoma, follicular – anaplastik – papillary carcinoma, papillary – follicular carcinoma have been presented. The cases reported up to now had no thyroid autoimmunity. We present a case with known Hashimoto’s thyroiditis having a combination o...

ea0029p1187 | Obesity | ICEECE2012

Metabolic syndrome in benign and malignant nodular thyroid diseases

Can S. , Anil C. , Nar A. , Gursoy A. , Tutuncu N Bascil

Introduction: Metabolic syndrome (MetS) is a group of metabolic abnormalities where insulin resistance (IR) plays a major role. Previous studies have shown that thyroid volume and nodule prevalence were increased in patients with IR. The aim of our study is to evaluate MetS and its components in patients with benign and malignant nodular thyroid disease (NTD).Methods: A total of 800 patients (430 euthyroid benign and 370 euthyroid malignant NTD) followed...

ea0029p1234 | Obesity | ICEECE2012

How informative is visceral fat measurement by bioelectrical impedance?

Mousa U. , Kut A. , Bozkus Y. , Cicek Demir C. , Anil C. , Bascil Tutuncu N.

Although obesity is a powerful risk factor for developing metabolic syndrome (MetS), it is not present in all obese individuals. Increased visceral adipose tissue is the hallmark of this syndrome. In this cross sectional survey abdominal bioelectrical impedence was used to measure the visceral adipose tissue (VAT) and trunk fat percentages (TF%) in participants. A total of 286 patients (196 female and 90 males) were enrolled in the study. In both sexes VAT was significantly po...

ea0029p1267 | Obesity | ICEECE2012

Is fat mass index superior to total fat mass percentage in predicting the metabolic syndrome?

Bozkus Y. , Kut A. , Mousa U. , Demir C. , Anil C. , Tutuncu N.

Aim: We aimed to compare the cut off values, defined to express the excess total body fat (TBF) percentange and increased fat mass index (FMI) as predictors of metabolic syndrome (MS).Subjects and methods: A total of 162 obese (body mass index (BMI) >30 kg/m2) subjects’ TBF were measured by ‘Tanita TBF 300 Body Composition Analyzer’. Patients were divided into two groups called normal obese (NO) and fatty obese (FO) accordin...

ea0029p1651 | Thyroid (non-cancer) | ICEECE2012

Evaluation of health related quality of life and general symptoms in Hashimoto's thyroiditis: are factors other than thyroid function effective? Analysis of preliminary results

Anil C. , Kut A. , Demir C. , Mousa U. , Bozkus Y. , Bascil Tutuncu N.

Introduction: Factors affecting health related quality of life (HRQOL) in Hashimoto’s thyroiditis (HT) are controversial and research on the topic is limited. This study aimed to evaluate the factors that may affect HRQOL and admitting symptoms in a group of patients with HT.Methods: For the evaluation of HRQOL, SF-36, Beck anxiety scale and Beck depression scale were performed on subsequent 57 cases with HT admitting to outpatient clinic of Endocri...

ea0016p181 | Diabetes and cardiovascular diseases | ECE2008

The impact of family history of type 2 diabetes mellitus on insulin sensitivity in lean subjects with polycystic ovary syndrome

Bozkirli Emre , Ertorer M Eda , Bakiner Okan , Anaforoglu Inan , Tutuncu N Bascil , Demirag N Guvener

Objective: Polycystic ovary syndrome (PCOS) is a common endocrine disorder, characterized by hyperandrogenism and chronic anovulation. Hyperinsulinemia and insulin resistance are well-documented features of the disease. In obese PCOS patients, family history of type 2 diabetes mellitus (FH-DM) is shown to be related with a decrease in insulin sensitivity, however not much is known about lean PCOS cases. The aim of this study was to determine the relationship between FH-DM and ...

ea0029p714 | Diabetes | ICEECE2012

Antidiabetic therapies and malignancy: a retrospective study in oncological cases.

Anil C. , Demir C. , Erismis B. , Can S. , Yalcin S. , Altundag O. , Gunes G. , Bascil Tutuncu N.

Introduction: Despite the relation between Type 2 Diabetes Mellitus (DM) and development of malignancy is well known, data on antidiabetic drugs and cancer risk is contradictory. Thesis which have suggested that analogue insulins, especially glargine, increase cancer risk, has not been validated. The present study aimed to evaluate the possible contributions of diabetes durations and medications to the type and course of malignancy in patients with both diabetes and malignancy...